Rabavert (Bavarian Nordic) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

(MENAFN- GlobeNewsWire - Nasdaq) Opportunities in the Rabavert market include rising demand due to increasing rabies cases, pet ownership, and government initiatives. Expansion in vaccine manufacturing, travel-related immunization, and digital records can boost growth. The Asia-Pacific region leads in growth, while tariffs drive local manufacturing efforts.

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Rabavert Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets's offering.

The Rabavert market encompasses a broad range of products, notably including various vaccine formats such as injections and lyophilized forms. Revenue analysis focuses on sales values direct from manufacturers to entities along the supply chain. These insights, captured in market reports, provide a comprehensive view of Rabavert's current and future market dynamics, emphasizing the vaccine's critical role in combating rabies globally.

The Rabavert market is experiencing significant growth, driven by multiple factors. Historical growth is largely due to rising animal bite exposures, enhanced public health immunization efforts, improved vaccine accessibility, expansion in veterinary and wildlife services, and heightened awareness of rabies prevention measures.

Looking ahead, the market is set to benefit from increased investments in vaccine production, growing demand for travel immunizations, and expanded public-private vaccination initiatives. Trends include a focus on zoonotic disease prevention, digital immunization records, preventive vaccination programs, and enhanced vaccine safety monitoring.

The increase in rabies cases directly fuels the Rabavert market's growth. Rabavert serves dual roles by offering post-exposure prophylaxis and pre-exposure prevention, invigorating the immune response against rabies. With cases rising due to inadequate animal vaccination, low public awareness, and healthcare access issues in rural areas, Rabavert's importance is underscored. A stark example is the 122% rise in rabies cases reported by South Dakota's Department of Health, from nine cases in 2022 to 20 in 2023.

Additionally, the Rabavert market is bolstered by an uptick in pet ownership. As pets become integral companions, pet owners are increasingly seeking comprehensive care, including rabies vaccination via Rabavert. Notably, the People's Dispensary for Sick Animals estimated pet statistics, showing significant pet ownership in the UK, influencing the demand for rabies vaccines.

Government initiatives further accelerate Rabavert market growth. Rabavert is pivotal to public health drives, offering a dependable vaccine that supports rabies prevention campaigns and improves access to key treatments. With millions in the US requiring exposure prophylaxis annually, costing over $600 million in prevention efforts, government strategies heavily lean on vaccines like Rabavert.

The Rabavert market is highly influenced by companies like Bavarian Nordic A/S. North America led the market in 2025, while Asia-Pacific is expected to grow rapidly. Regions included in studies span Asia-Pacific, Europe, North and South America, and regions within the Middle East and Africa, covering countries like the USA, UK, China, and others.

Report Scope:

• Markets Covered:
  • By Indication: Pre-Exposure Prophylaxis (PrEP); Post-Exposure Prophylaxis (PEP)
  • By Distribution Channel: Direct Sales; Wholesalers or Distributors; Online Pharmacies
  • By End User: Hospitals; Clinics; Public Health Organizations
• Key Players: Bavarian Nordic A/S
• Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
• Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Major Trends

• Increasing Adoption of Preventive Vaccination Programs
• Rising Demand for Post-Exposure Prophylaxis Vaccines
• Growing Focus on Occupational Immunization Coverage
• Expansion of Cold-Chain Vaccine Distribution
• Enhanced Vaccine Safety Monitoring

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN07052026004107003653ID1111082094